New pill aims to tame high blood pressure better than current standard
NCT ID NCT06643819
Summary
This large Phase 3 trial is testing whether a new combination drug called CKD-202A works better than a common standard medication (valsartan) at lowering high blood pressure. It will involve 324 adults with essential hypertension. The study is designed to see if the new drug provides superior blood pressure control over 24 hours.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wonju Severance Christian Hospital
RECRUITINGWŏnju, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.